Melissa Cooper

1.0k total citations
11 papers, 84 citations indexed

About

Melissa Cooper is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Melissa Cooper has authored 11 papers receiving a total of 84 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 4 papers in Virology and 4 papers in Epidemiology. Recurrent topics in Melissa Cooper's work include SARS-CoV-2 and COVID-19 Research (4 papers), HIV Research and Treatment (4 papers) and vaccines and immunoinformatics approaches (3 papers). Melissa Cooper is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (4 papers), HIV Research and Treatment (4 papers) and vaccines and immunoinformatics approaches (3 papers). Melissa Cooper collaborates with scholars based in United States, India and Ireland. Melissa Cooper's co-authors include F. Heath Damron, Ting Y. Wong, Seyed Davoud Jazayeri, Kingston H. G. Mills, Martin Rosenberg, Aaron J. Kowalski, Chi-I Chiang, E. J. Arcuri, Katherine S. Lee and Justin R. Bevere and has published in prestigious journals such as Scientific Reports, Clinical Chemistry and Frontiers in Immunology.

In The Last Decade

Melissa Cooper

11 papers receiving 83 citations

Peers

Melissa Cooper
Joshua Mills United States
Dinah Amante United States
Charline Giroud United States
Rupert Hugh-White United Kingdom
Claudia Carbone United States
Jennifer L. Shields United States
Samantha Falcone United States
Joshua Mills United States
Melissa Cooper
Citations per year, relative to Melissa Cooper Melissa Cooper (= 1×) peers Joshua Mills

Countries citing papers authored by Melissa Cooper

Since Specialization
Citations

This map shows the geographic impact of Melissa Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa Cooper more than expected).

Fields of papers citing papers by Melissa Cooper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa Cooper. The network helps show where Melissa Cooper may publish in the future.

Co-authorship network of co-authors of Melissa Cooper

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa Cooper. A scholar is included among the top collaborators of Melissa Cooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa Cooper. Melissa Cooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Lee, Katherine S., Melissa Cooper, Holly A. Cyphert, et al.. (2025). SARS-CoV-2 mRNA vaccines confer protection in diet-induced obese mice despite altered immune cell profiles in the lung. Scientific Reports. 15(1). 27209–27209. 1 indexed citations
2.
Lee, Katherine S., Andrea N. Loes, Melissa Cooper, et al.. (2024). Influenza virus strains expressing SARS-CoV-2 receptor binding domain protein confer immunity in K18-hACE2 mice. Vaccine X. 20. 100543–100543. 2 indexed citations
4.
Cooper, Melissa, Ting Y. Wong, Md Shahrier Amin, et al.. (2023). Intranasal VLP-RBD vaccine adjuvanted with BECC470 confers immunity against Delta SARS-CoV-2 challenge in K18-hACE2-mice. Vaccine. 41(34). 5003–5017. 7 indexed citations
5.
Barbier, Mariette, Katherine S. Lee, Ting Y. Wong, et al.. (2022). Passive immunization with equine RBD-specific Fab protects K18-hACE2-mice against Alpha or Beta variants of SARS-CoV-2. Frontiers in Immunology. 13. 948431–948431. 4 indexed citations
6.
Xia, Shi-Mao, Robert Parks, Haiyan Chen, et al.. (2021). Rapid selection of HIV envelopes that bind to neutralizing antibody B cell lineage members with functional improbable mutations. Cell Reports. 36(7). 109561–109561. 4 indexed citations
7.
Meyerhoff, Robert, Richard M. Scearce, Joy Pickeral, et al.. (2017). HIV-1 Consensus Envelope-Induced Broadly Binding Antibodies. AIDS Research and Human Retroviruses. 33(8). 859–868. 8 indexed citations
8.
Yu, Jae‐Sung, Hua‐Xin Liao, Cindy Bowman, et al.. (2017). Development of a recombinant yellow fever vector expressing a HIV clade C founder envelope gp120. Journal of Virological Methods. 249. 85–93. 2 indexed citations
11.
Chiang, Chi-I, et al.. (1989). Development of a confirmatory enzyme-linked immunosorbent assay for HIV-1 antibodies.. Clinical Chemistry. 35(6). 946–952. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026